Oxygenta Pharmaceutical reports standalone net loss of Rs 3.36 crore in the December 2023 quarter
Sales rise 16.56% to Rs 9.15 crore
Net Loss of Oxygenta Pharmaceutical reported to Rs 3.36 crore in the quarter ended December 2023 as against net loss of Rs 3.25 crore during the previous quarter ended December 2022. Sales rose 16.56% to Rs 9.15 crore in the quarter ended December 2023 as against Rs 7.85 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales9.157.85 17 OPM %-27.10-29.68 -PBDT-2.81-2.51 -12 PBT-3.50-2.91 -20 NP-3.36-3.25 -3Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content